Literature DB >> 12820723

Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.

Y Nemoto-Sasaki1, M Mitsuki, M Morimoto-Tomita, A Maeda, M Tsuiji, T Irimura.   

Abstract

The cell surface glycosylation profiles of a liver metastatic colon carcinoma variant cell line, SL4 cells previously selected from colon 38 cells in vivo for liver colonization were investigated. Flowcytometric analysis was performed with 7 plant lectins and 10 carbohydrate specific monoclonal antibodies. The results showed that peanut agglutinin (PNA), Sambucus nigra agglutinin, Ulex europeus agglutinin-I, anti-LeX, anti-LeY, and anti-Le(b) antibodies bound to the parental colon 38 cells but not to SL4 cells. Another variant cell line was selected in vitro for the paucity of cell surface PNA-binding sites using a magnetic cell sorter and was designated as 38-N4 cells. The binding profiles of plant lectins and carbohydrate-specific antibodies to 38-N4 cells were very similar to those of SL4 cells. After intrasplenic injections, metastatic ability of 38-N4 cells was higher than that of colon 38 cells. PNA binding to SL4 cells and 38-N4 cells was detected after sialidase treatment of these cells, indicating increased sialylation of Thomsen-Friedenreich antigen in these cells. The mRNA levels of sialyltransferases, ST3Gal I, ST3Gal II, ST6GalNAc I, and ST6GalNAc II, were compared. The level of ST3Gal II mRNA was elevated in both SL4 cells and 38-N4 cells, whereas the level of ST6GalNAc II mRNA was elevated in 38-N4 cells compared with colon 38 cells. According to the expression array analysis, there are other glycosyltransferase genes differentially expressed between SL4 and colon 38 cells, yet their involvement in the altered glycosylation in these cells is unclear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12820723     DOI: 10.1023/a:1022252509765

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  59 in total

1.  Molecular cloning of mouse acid beta-galactosidase cDNA: sequence, expression of catalytic activity and comparison with the human enzyme.

Authors:  E Nanba; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1990-11-30       Impact factor: 3.575

2.  Systematic nomenclature for sialyltransferases.

Authors:  S Tsuji; A K Datta; J C Paulson
Journal:  Glycobiology       Date:  1996-10       Impact factor: 4.313

3.  Purification and characterization of neuraminidase from Clostridium perfringens.

Authors:  C H Chien; S C Chang; Y H Wei
Journal:  Proc Natl Sci Counc Repub China B       Date:  1989-07

4.  Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation.

Authors:  Y Cao; U R Karsten; W Liebrich; W Haensch; G F Springer; P M Schlag
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

5.  Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.

Authors:  F Schneider; W Kemmner; W Haensch; G Franke; S Gretschel; U Karsten; P M Schlag
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

6.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-Lewis(a) structure.

Authors:  H Tsuiji; J C Hong; Y S Kim; Y Ikehara; H Narimatsu; T Irimura
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

8.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

9.  Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides.

Authors:  K Yamamoto; C Ishida; Y Shinohara; Y Hasegawa; Y Konami; T Osawa; T Irimura
Journal:  Biochemistry       Date:  1994-07-05       Impact factor: 3.162

10.  The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins.

Authors:  A P Corfield; H Higa; J C Paulson; R Schauer
Journal:  Biochim Biophys Acta       Date:  1983-04-28
View more
  9 in total

1.  Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Authors:  Megumi Morimoto-Tomita; Yoshimi Ohashi; Azusa Matsubara; Makoto Tsuiji; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells.

Authors:  Robert Brodzik; Magdalena Glogowska; Katarzyna Bandurska; Monika Okulicz; Deepali Deka; Kisung Ko; Joke van der Linden; Jeanette H W Leusen; Natalia Pogrebnyak; Maxim Golovkin; Zenon Steplewski; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-23       Impact factor: 11.205

3.  Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.

Authors:  Hironori Kumagai; Wellington Pham; Makoto Kataoka; Ken-Ichiro Hiwatari; James McBride; Kevin J Wilson; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Eric H Liu; John C Gore; Shinji Sakuma
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

4.  Photo- and biophysical studies of lectin-conjugated fluorescent nanoparticles: reduced sensitivity in high density assays.

Authors:  Yaqi Wang; Jeffrey C Gildersleeve; Amit Basu; Matthew B Zimmt
Journal:  J Phys Chem B       Date:  2010-05-24       Impact factor: 2.991

5.  Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems.

Authors:  Kevin A Maupin; Arkadeep Sinha; Emily Eugster; Jeremy Miller; Julianna Ross; Vincent Paulino; Venkateshwar G Keshamouni; Nhan Tran; Michael Berens; Craig Webb; Brian B Haab
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

6.  Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.

Authors:  Kentaro Kato; Hideyuki Takeuchi; Akira Kanoh; Naoki Miyahara; Yoko Nemoto-Sasaki; Megumi Morimoto-Tomita; Azusa Matsubara; Yoshimi Ohashi; Michihiko Waki; Katsuaki Usami; Ulla Mandel; Henrik Clausen; Nobuaki Higashi; Tatsuro Irimura
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

Review 7.  Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer.

Authors:  Jung-Jin Park; Minyoung Lee
Journal:  Gut Liver       Date:  2013-11-11       Impact factor: 4.519

8.  Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).

Authors:  Marina Isla Larrain; Sandra Demichelis; Marina Crespo; Ezequiel Lacunza; Alberto Barbera; Aldo Cretón; Francisco Terrier; Amada Segal-Eiras; María Virginia Croce
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28

Review 9.  Production of monoclonal antibodies in plants for cancer immunotherapy.

Authors:  Ghislain Moussavou; Kisung Ko; Jeong-Hwan Lee; Young-Kug Choo
Journal:  Biomed Res Int       Date:  2015-10-15       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.